Event Date
Thu 20 Sep 2018 15:00

The National Drug and Alcohol Research Centre is pleased to present:

Dr Alys Havard (Centre for Big Data Research in Health, UNSW)
“The cardiovascular safety of smoking cessation pharmacotherapies”

Thursday, 25 October 3.00pm-4.00pm

About the speaker:

Dr Alys Havard is a Senior Research Fellow in the Centre for Big Data Research in Health at the University of New South Wales (UNSW). Her primary research interest is in using linked administrative datasets for tobacco control research and for examining the utilisation and safety of prescription medications.

Dr Havard recently completed an NHMRC-funded Early Career Fellowship in which she examined the epidemiology of smoking and smoking cessation medications using data from the 45 and Up Study linked to health services data. She is currently undertaking a National Heart Foundation-funded Future Leader Fellowship in which she is examining the safety of smoking cessation medications in the general population, as well as methods for measuring depression from routinely collected health data. Dr Havard is also currently leading an NHMRC-funded project investigating the use, effectiveness and safety of smoking cessation medications prior to and during pregnancy, with a particular focus on Aboriginal women.

Location
NDARC Seminar Room: Building R1, UNSW Australia Randwick Campus, 22 - 32 King Street, Randwick (visitors please report to reception in building R3)

Cost
Free - no booking required

Open to
Public

Contact
NDARC reception +61 (2) 9385 0333